DOLF and DOLF-Affiliated Researcher Presentations at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference

Monday, October 31, 2022
PresenterSession Name#Abstract TitleTimeLocation
Catherine BjerumSession 9 – Filariasis – Clinical, Immunology, Diagnostics35Moxidectin combination therapy for lymphatic filariasis is superior to ivermectin plus albendazole for clearance of microfilaremia at 12 months post-treatment8:00 – 8:15 amConvention Center – Room 611/612
Peter FischerSession 9 – Filariasis – Clinical, Immunology, Diagnostics36Partial macrofilaricidal activity of ivermectin, diethylcarbamazine and albendazole combination treatment for human onchocerciasis8:15 – 8:30 amConvention Center – Room 611/612
Bruce RosaSession 9 – Filariasis – Clinical, Immunology, Diagnostics3919 Onchocerciasis Biomarker Candidates Identified Directly in Human Serum and Urine9:00 – 9:15 amConvention Center – Room 611/612
Sarah GreeneSession 14 – Poster Session A Presentations192A SARS-CoV-2 Antibody Lateral Flow Assay Provides a Semi-quantitative Assessment of Anti-Spike Antibody Responses After SARS-CoV-2 Vaccination11:00 – 12:45 pmConvention Center – Hall 4A
Young-Jun ChoiSession 16 – Late-Breakers in Basic ScienceLB-5161Distinguishing recrudescence from reinfection in lymphatic filariasis: a genomics-based approach for monitoring worm burden11:55 – 12:05 pm Convention Center – Room 602/603/604
Tania SupaliSession 35 – Filariasis – Epidemiology and Control608Detection of Brugia malayi eleven years after stopping mass drug administration to eliminate lymphatic filariasis in Belitung district, Indonesia4:15 – 4:30 pmConvention Center – Room 611/612
Tuesday, November 1, 2022
PresenterSession Name#Abstract TitleTimeLocation
Obi EneanyaSession 63 – Poster Session B Presentations1666Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia12:00 – 1:45 pmConvention Center – Hall 4A
Wednesday, November 2, 2022
PresenterSession Name#Abstract TitleTimeLocation
Linda DjuneSession 102 – Poster Session C Presentations1058Cytokines responses to ivermectin treatment of low-to-moderate L. loa infections differ from W. bancrofti infections, suggesting roles for Wolbachia in the emergence of post treatment adverse events in filarial infections11:00 – 12:45 pmConvention Center – Hall 4A
Lucia Sanchez DiMaggioSession 102 – Poster Session C Presentations1707Paragonimus kellicotti excretion/secretion products: comparative proteomics of in vitro and in vivo release11:00 – 12:45 pmConvention Center – Hall 4A
Devyn YatesSession 102 – Poster Session C PresentationsLB – 5338Brugia malayi exosomes: Comparison of extracellular vesicle isolation methods for analysis by mass spectrometry11:00 – 12:45 pmConvention Center – Hall 4A

Leave a Reply

Your email address will not be published. Required fields are marked *